Skip to main content

Advertisement

Log in

Potentialities of Cashew Nut (Anacardium occidentale) By-Product for Pharmaceutical Applications: Extraction and Purification Technologies, Safety, and Anti-inflammatory and Anti-arthritis Activities

  • Original Article
  • Published:
Revista Brasileira de Farmacognosia Aims and scope Submit manuscript

Abstract

The large consumption of cashew nut from Anacardium occidentale L., Anacardiaceae, generates accumulation of shells, a solid by-product from agri-food industry. The cashew nut shell liquid is rich in phenolic lipids, recognized for its anti-inflammatory and anti-tumor properties, and the shell of this fruit carry the great oil. For these reasons, this study aimed to investigate the potential of the residual shells as a source of phenolic lipids and bioactive extract for pharmaceutical applications. The ethyl acetate extract from the oil of the chestnut bark of A. occidentale (M3 extract) was optimized to obtain a phenolic lipid-rich extract and preparative chromatography was used to increase the yield of isolated phenolic lipid derivatives. In addition, the toxicity profile, anti-inflammatory, and acute and chronic anti-arthritis activities of the M3 extract were evaluated in in vivo models. The M3 extract (25–100 mg/kg) on zymosan-induced air pouch and arthritis models revealed a significant anti-edematogenic, antioxidant, and anti-inflammatory potential. The post-treatment with M3 extract at dose of 100 mg/kg dependently improved a complete Freud’s adjuvant-induced arthritis model, with prevention osteoarticular degradation. Therefore, these results report that bioactive M3 extract obtained from by-product is safe, eco-friendly, and promising for the rheumatoid arthritis therapy.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

Download references

Acknowledgments

The authors acknowledge all contributors for their valuable time and commitment to the study. This research received no external funding in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001. We also thank to Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brasil (CNPq) for the financial support (478661/2010-0) and the Federal University of Rio Grande do Norte (UFRN).

Author information

Authors and Affiliations

Authors

Contributions

ATS, SMZ, and GCBG planned and designed the experiments. ATS, JIM, MT-R, JSFA, RCV, and DFSA performed and designed of experiments. ATS, LSA, MT-R, TGC, RCV, and DFSA performed data analysis. SMZ, GCBG, JFT, MGA, AAA, RFAJ, MFF-P, and LSF collaborated with the preparation of materials/reagents/kits and analytical tools. ATS, SMZ, GCBG, MFF-P, JSFA, and MT-R collaborated with the preparation of the manuscript and critical analyses of the text.

Corresponding author

Correspondence to Silvana Maria Zucolotto.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic Supplementary Material

ESM 1

(DOCX 45 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

dos Santos, A.T., Guerra, G.C.B., Marques, J.I. et al. Potentialities of Cashew Nut (Anacardium occidentale) By-Product for Pharmaceutical Applications: Extraction and Purification Technologies, Safety, and Anti-inflammatory and Anti-arthritis Activities. Rev. Bras. Farmacogn. 30, 652–666 (2020). https://doi.org/10.1007/s43450-020-00090-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43450-020-00090-w

Keywords

Navigation